Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04886076 · ClinicalTrials.gov registry record
Sleep Profiles in REM Sleep Behavior Disorder
A clinical trial of Rapid Eye Movement Sleep Behavior Disorder, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT04886076 is a study of Rapid Eye Movement Sleep Behavior Disorder that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04886076, a study of Rapid Eye Movement Sleep Behavior Disorder, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Rapid eye movement (REM) sleep behavior disorder (RBD) is a sleep disorder in which you act out dreams during REM sleep. Sleep disturbances are very common in RBD, where they negatively impact patients' quality of life and safety. One of the known causes of sleep disturbance is the impairment of the "circadian rhythm", or the human sleep/wake cycle. The purpose of this study is to examine the role of disruption of the circadian rhythm in the development of RBD.
Conditions Studied
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-12-07 |
| Est. Completion | 2026-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04886076
The ClinicalTrials.gov registry entry for NCT04886076 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rapid Eye Movement Sleep Behavior Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT04886076 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04886076 about?
NCT04886076 is a clinical study titled "Sleep Profiles in REM Sleep Behavior Disorder". Rapid eye movement (REM) sleep behavior disorder (RBD) is a sleep disorder in which you act out dreams during REM sleep. Sleep disturbances are very common in RBD, where they negatively impact patients' quality of life and safety. One of the known causes of sleep disturbance is the impairment of the...
What is the current status of trial NCT04886076?
This trial is currently active not recruiting. The enrollment target is 30 participants. The study started on 2018-12-07. Estimated completion is 2026-11.
What conditions does trial NCT04886076 study?
This clinical trial studies the following conditions: Rapid Eye Movement Sleep Behavior Disorder.
Who is sponsoring clinical trial NCT04886076?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04886076 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.